Transcriptome Sequencing Finds Diagnostic Mutation for Rare Ovarian Tumor Type

The study, published online last week in the New England Journal of Medicine, underscores how next-generation sequencing can directly benefit the clinic and indicates that whole-genome sequencing may not always be needed to discover important cancer mutations.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.